The University of Southampton
University of Southampton Institutional Repository

The use of Surgihoney to prevent or eradicate bacterial colonisation in dressing oncology long vascular lines

The use of Surgihoney to prevent or eradicate bacterial colonisation in dressing oncology long vascular lines
The use of Surgihoney to prevent or eradicate bacterial colonisation in dressing oncology long vascular lines

Objective: A pilot evaluation was performed to assess the effects of Surgihoney, an engineered honey with highly active antimicrobial activity, on bacterial colonisation in long lines in oncology patients.

Method: This prospective service evaluation was conducted at Hampshire Hospitals NHS Foundation Trust (HHFT) in England, UK, between 2012 and 2013. The study population consisted of oncology patients with central intravenous lines who were receiving outpatient chemotherapy. All patients were offered line dressing with or without Surgihoney, applied to the line exit site.

Results: The primary outcome measure of the study was the presence or absence of bacterial colonisation of the line site. There were 30 patients in each arm - with or without Surgihoney. In the Surgihoney arm, 2 patients with existing line site colonisation were cleared of bacterial colonisation and none acquired colonisation during the study period. In the non-treatment arm, 6 patients were colonised at the line site prior to screening or during the evaluation. Bacterial colonisation was maintained throughout the period.

Conclusion: Surgihoney is an effective antimicrobial line-site dressing, significantly reducing line site colonisation and eradicating existing colonisation. It was well tolerated by the patients.

Declaration of interest: Surgihoney supplies were donated by Healing Honey International (HHI) who also provided some funding to Hampshire Hospitals Foundation Trust for microbiological investigation. MD and JC have provided clinical advice in an advisory capacity to HHI.

Central lines, Exit site, Honey, Immunocompromised, IV line infections
0969-0700
338-341
Dryden, M.
a6c300f9-5c26-4884-980b-c098b0688ab1
Tawse, C.
25b2f3e7-c416-4a19-91e5-cda68a65c967
Adams, J.
fb14d6d8-20f9-40b9-8dec-5f86c553d5a5
Howard, A.
620d87f5-647a-404c-834a-8d8dd09781dd
Saeed, K.
87cb67e5-71e8-4759-bf23-2ea00ebd8b39
Cooke, J.
c18de703-28c1-4809-a810-725dfbc1cee8
Dryden, M.
a6c300f9-5c26-4884-980b-c098b0688ab1
Tawse, C.
25b2f3e7-c416-4a19-91e5-cda68a65c967
Adams, J.
fb14d6d8-20f9-40b9-8dec-5f86c553d5a5
Howard, A.
620d87f5-647a-404c-834a-8d8dd09781dd
Saeed, K.
87cb67e5-71e8-4759-bf23-2ea00ebd8b39
Cooke, J.
c18de703-28c1-4809-a810-725dfbc1cee8

Dryden, M., Tawse, C., Adams, J., Howard, A., Saeed, K. and Cooke, J. (2014) The use of Surgihoney to prevent or eradicate bacterial colonisation in dressing oncology long vascular lines. Journal of Wound Care, 23 (6), 338-341. (doi:10.12968/jowc.2014.23.6.338).

Record type: Article

Abstract

Objective: A pilot evaluation was performed to assess the effects of Surgihoney, an engineered honey with highly active antimicrobial activity, on bacterial colonisation in long lines in oncology patients.

Method: This prospective service evaluation was conducted at Hampshire Hospitals NHS Foundation Trust (HHFT) in England, UK, between 2012 and 2013. The study population consisted of oncology patients with central intravenous lines who were receiving outpatient chemotherapy. All patients were offered line dressing with or without Surgihoney, applied to the line exit site.

Results: The primary outcome measure of the study was the presence or absence of bacterial colonisation of the line site. There were 30 patients in each arm - with or without Surgihoney. In the Surgihoney arm, 2 patients with existing line site colonisation were cleared of bacterial colonisation and none acquired colonisation during the study period. In the non-treatment arm, 6 patients were colonised at the line site prior to screening or during the evaluation. Bacterial colonisation was maintained throughout the period.

Conclusion: Surgihoney is an effective antimicrobial line-site dressing, significantly reducing line site colonisation and eradicating existing colonisation. It was well tolerated by the patients.

Declaration of interest: Surgihoney supplies were donated by Healing Honey International (HHI) who also provided some funding to Hampshire Hospitals Foundation Trust for microbiological investigation. MD and JC have provided clinical advice in an advisory capacity to HHI.

This record has no associated files available for download.

More information

e-pub ahead of print date: 11 June 2014
Additional Information: Publisher Copyright: © 2014 MA Healthcare ltd. Copyright: Copyright 2015 Elsevier B.V., All rights reserved.
Keywords: Central lines, Exit site, Honey, Immunocompromised, IV line infections

Identifiers

Local EPrints ID: 447290
URI: http://eprints.soton.ac.uk/id/eprint/447290
ISSN: 0969-0700
PURE UUID: 1327b955-21dc-42ff-b6d8-5a6a25b25049
ORCID for K. Saeed: ORCID iD orcid.org/0000-0003-0123-0302

Catalogue record

Date deposited: 08 Mar 2021 17:33
Last modified: 10 Jun 2022 01:53

Export record

Altmetrics

Contributors

Author: M. Dryden
Author: C. Tawse
Author: J. Adams
Author: A. Howard
Author: K. Saeed ORCID iD
Author: J. Cooke

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×